Back to BlackRock, Inc. BlackRock, Inc.

AVBPAVBP
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ARRIVENT BIOPHARMA INC

BlackRock, Inc. holds 3.3M shares of AVBP (ARRIVENT BIOPHARMA INC), worth $112.9M as of 2026-Q2. The position was increased (+28.5% shares). AVBP represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$112.9M

Current Shares

3.3M

Total Value Change

+$56M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.3M
+28.5%
$112.9M0.0%$34.74
38
2026-Q1
Increased
2.5M
+6.6%
$58.4M0.0%$23.94
31
2025-Q4
Increased
2.4M
+16.0%
$47.7M0.0%$20.72
34
2025-Q3
Increased
2M
+11.3%
$37.8M0.0%$18.16
32
2025-Q2
Decreased
1.8M
-14.1%
$40M0.0%$22.91
0
2025-Q1
Increased
2.1M
+0.2%
$39.6M0.0%$18.95
29
2024-Q4
New
2.1M
-
$56.9M0.0%$26.95
41

Other major holders of AVBP: HHLR ADVISORS, LTD., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used